Document Detail


Peripheral neuropathy during alpha-interferon therapy in a child with Hodgkin's disease.
MedLine Citation:
PMID:  10599097     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Peripheral neuropathy is one of the rarely reported neurological complications of interferon therapy. The authors report such a case in a 15-year-old boy during alpha-interferon therapy for Hodgkin's disease. He received alpha-interferon at a dose of 1.8 million units/day 5 times a week by subcutaneous injections as adjuvant immunotherapy post autologous stem cell transplant. Twenty months after the initiation of therapy, he complained of severe pain in his lower distal extremities. Neurological examination revealed the absence of deep tendon reflexes. A nerve conduction study showed a sensorial, polyneuropathic involvement in the lower extremities. Within 4 weeks after the stopping of interferon, his pain improved, and recovery was also seen by nerve conduction studies. Symptoms reappeared at the resumption of interferon treatment. This study suggests that peripheral neuropathy may rarely occur in patients given long-term interferon treatment at high cumulative dosage.
Authors:
S Emir; T Kutluk; K W Chan; B Yalçin; K Varli; M Büyükpamukçu
Related Documents :
12968087 - Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients ...
2843137 - Failure of intraventricular gammaglobulin and alpha interferon for persistent encephali...
8314477 - Recombinant interferon alfa-2b treatment in chronic non-a, non-b/type c hepatitis.
15964537 - Haart with didanosine once versus twice daily: adherence and efficacy.
19483077 - Bioresorbable pins and interference screws for fixation of hamstring tendon grafts in a...
24285457 - Effectiveness and safety of topical emollients in the treatment of puva-induced pruritus.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pediatric hematology and oncology     Volume:  16     ISSN:  0888-0018     ISO Abbreviation:  Pediatr Hematol Oncol     Publication Date:    1999 Nov-Dec
Date Detail:
Created Date:  2000-02-16     Completed Date:  2000-02-16     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8700164     Medline TA:  Pediatr Hematol Oncol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  557-60     Citation Subset:  IM    
Affiliation:
Department of Pediatric Oncology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Hodgkin Disease / drug therapy*
Humans
Interferon-alpha / adverse effects*,  therapeutic use
Male
Peripheral Nervous System Diseases / chemically induced*
Chemical
Reg. No./Substance:
0/Interferon-alpha
Comments/Corrections
Comment In:
Pediatr Hematol Oncol. 1999 Nov-Dec;16(6):499-500   [PMID:  10599088 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Continuous infusion of von Willebrand factor and factor VIII after elective heart surgery in a 12-ye...
Next Document:  Postinfection purpura fulminans in a patient heterozygous for prothrombin G20210A and acquired prote...